Tag: Chinook
Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and...
NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is...
Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy...
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60...
CHINOOK INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encour… –...
NEW YORK, May 20, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Chinook...
Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer...
SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development...
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule...
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and...